Reuters logo
BRIEF-Lundbeck and Otsuka will start third clinical phase III study
November 1, 2017 / 6:16 AM / in 22 days

BRIEF-Lundbeck and Otsuka will start third clinical phase III study

Nov 1 (Reuters) - LUNDBECK:

* ‍H. LUNDBECK A/S AND OTSUKA ANNOUNCE WILL INITIATE A THIRD CLINICAL PHASE III STUDY FOR BREXPIPRAZOLE​

* ‍TRIAL IS EXPECTED TO COMMENCE DURING FIRST HALF OF 2018​

* ‍STUDY IS FOR BREXPIPRAZOLE IN TREATMENT OF AGITATION IN PATIENTS WITH DEMENTIA OF ALZHEIMER‘S TYPE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below